Type 2 diabetes trials in India

In India 32 Also abroad 1200

32 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Ahmedabad, Mumbai, Pune, Trivandrum
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Ahmedabad, Chennai, Hyderabad, Indore, Mumbai, Pune, Trivandrum
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
Phase 3Not yet taking people in India
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
Where
Ansārinagar, Calicut, Kolkata, Ludhiana, Meerut, Surat
Age
18 years and over
People
330 worldwide
Run by
AstraZeneca
See details and how to joinNCT07922330
Phase 3Taking people
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Where
Ahmedabad, Aligarh, Bhubaneswar, Guntur, Mumbai, Nashik, New Delhi
Age
10 years to 17 years
People
170 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07668336 · EU 2025-524811-35-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Where
Bangalore
Age
18 years and over
People
1,035 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Where
Allahabād, Bangalore, Chennai, Hyderabad, Jaipur, Kanpur, Kolhāpur, Mysore, Nagpur, Surat
Age
18 years and over
People
900 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00
Phase 3Not yet taking people in India
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Where
Ahmedabad, Baroda, Belagavi, Chennai, Guntur, Hubli, Kanpur, Noida, Pune, Raipur, Udaipur, Vellore
Age
18 years and over
People
2,115 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881432 · EU 2026-526047-34-00
Phase 3Not yet taking people in India
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Belagavi, Guntur, Guwahati, Mumbai, Nagpur, Pune, Rishikesh, Surat
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Where
Bangalore, Belagavi, Calicut, Chennai, Coimbatore, Guwahati, Indore, Jaipur, Kochi, Lucknow, Madurai, Mumbai, Nagpur, New Delhi, Thiruvananthapuram
Age
18 years and over
People
2,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Bhubaneswar, Coimbatore, Hyderabad, Indore, Jaipur, Jodhpur, Kochi, Kolkata, Noida, Pune, Siliguri, Surat, Vijayawada
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 3Taking people
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Where
Ahmedabad, Bhubaneswar, Cuttack, Hyderabad, Afzalgunj, Kolhāpur, Lucknow, Nagpur, Nashik, New Delhi, Pune, Trivandrum, Visakhapatnam
Age
18 years and over
People
600 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07754461
Phase 3Taking people
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Where
Ahmedabad, Bengaluru, Bikaner, Kanpur, Kolkata, Maharashtra, Nagpur, Nashik, New Dehi, New Delhi, Pune, Sāket, Surat, Trivandrum, Visakhapatnam
Age
18 years and over
People
11,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Where
Bangalore, Indore, Kolkata, Nagpur, Noida, Pune, Siliguri, Visakhapatnam
Age
18 years and over
People
1,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784270
Phase 3Taking people
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Where
Bangalore, Delhi, Guntur, Kanpur, Kolhāpur, Kolkata, New Delhi, Surat
Age
10 years to 18 years
People
80 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07282613
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Bangalore, Belagavi, Bikaner, Delhi, Guntur, Hyderabad, Jaipur, Jodhpur, Kolkata, Madurai, Mumbai, Mysore, Nagpur, New Delhi, Siliguri
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
Phase 3Taking people
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
Where
Agra, Hyderabad, Kanpur, Kolkata, Mumbai, Mysore, Nashik, Nellore, Visakhapatna
Age
18 years to 65 years
People
130 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07613307
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Where
Guntur, Guwahati, Hyderabad, Mandya, Mumbai, Mysore, Nagpur, Nashik, Pune, Trichy
Age
18 years and over
People
1,980 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00
No phaseTaking people
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Where
Ahmedabad, Kolkata, Mumbai
Age
18 years and over
People
35,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT03549754
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Where
Aligarh, Belagavi, Belgavi, Calicut, Chennai, Coimbatore, Delhi, Guntur, Kolkata, Lucknow, Nagpur, Pune
Age
18 years and over
People
900 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00
Phase 3Taking people
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Where
Bangalore, Bhubaneswar, Coimbatore, Guntur, Hyderabad, Indore, Jaipur, Kochi, Kozhikode, Ludhiana, Mumbai, Nagpur, New Delhi, Pune, Raipur, Surat, Thane, Vadodara, Vellore
Age
45 years and over
People
1,778 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07797335
No phaseTaking people
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
Where
Bangalore, Belagavi, Calicut, Chennai, Coimbatore, Delhi, Guntur, Guwahati, Indore, Jaipur, Kochi, Kolkata, Lucknow, Mumbai, Nagpur, Pune, Thiruvananthapuram
Age
18 years and over
People
2,150 worldwide
Run by
AstraZeneca
See details and how to joinNCT07606066
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
Where
Bangalore, Belagavi, Chennai, Coimbatore, Guntur, Hyderabad, Indore, Kochi, Madurai, Mumbai, New Delhi, Pune
Age
18 years and over
People
600 worldwide
Run by
AstraZeneca
See details and how to joinNCT07664553 · EU 2025-523935-20-00
No phaseEnrolling by invitation
Development of Anti-Diabetic Nutraceuticals From Legume Seed Coats
Where
Mysore
Age
20 years to 60 years
People
100
Run by
JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH
See details and how to joinNCT07688694
No phaseTaking people
Effect of Diode Laser, Gudmar and Vinegar in Diabetic Patients During Root Canal Treatment
Where
Noida
Age
25 years to 60 years
People
90
Run by
Sharda University
See details and how to joinNCT07549373
No phaseTaking people
Community Health Worker-Led Postpartum Diabetes Screening
Where
Pune
Age
18 years and over
People
330
Run by
Weill Medical College of Cornell University
See details and how to joinNCT06209411